Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival.

John F, Bosnyák E, Robinette NL, Amit-Yousif AJ, Barger GR, Shah KD, Michelhaugh SK, Klinger NV, Mittal S, Juhász C.

Neuro Oncol. 2019 Feb 14;21(2):264-273. doi: 10.1093/neuonc/noy169.

PMID:
30346623
2.

Glioblastoma metastatic to the ovary, a very different Krukenberg tumor?

Bonomi RE, Kovoor J, Zaki M, Szlaczky M, Christensen M, Kupsky W, Barger G, Miller S, Dominello MM.

Pract Radiat Oncol. 2018 Nov - Dec;8(6):373-375. doi: 10.1016/j.prro.2018.04.002. Epub 2018 Apr 7. No abstract available.

PMID:
29861347
3.

Amino Acid PET Imaging of the Early Metabolic Response During Tumor-Treating Fields (TTFields) Therapy in Recurrent Glioblastoma.

Bosnyák E, Barger GR, Michelhaugh SK, Robinette NL, Amit-Yousif A, Mittal S, Juhász C.

Clin Nucl Med. 2018 Mar;43(3):176-179. doi: 10.1097/RLU.0000000000001942.

PMID:
29261637
4.

Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.

Mittal S, Klinger NV, Michelhaugh SK, Barger GR, Pannullo SC, Juhász C.

J Neurosurg. 2018 Feb;128(2):414-421. doi: 10.3171/2016.9.JNS16452. Epub 2017 Feb 24.

PMID:
28298023
5.

Prognostic Molecular and Imaging Biomarkers in Primary Glioblastoma.

Bosnyák E, Michelhaugh SK, Klinger NV, Kamson DO, Barger GR, Mittal S, Juhász C.

Clin Nucl Med. 2017 May;42(5):341-347. doi: 10.1097/RLU.0000000000001577.

6.

Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.

Chang S, Zhang P, Cairncross JG, Gilbert MR, Bahary JP, Dolinskas CA, Chakravarti A, Aldape KD, Bell EH, Schiff D, Jaeckle K, Brown PD, Barger GR, Werner-Wasik M, Shih H, Brachman D, Penas-Prado M, Robins HI, Belanger K, Schultz C, Hunter G, Mehta M.

Neuro Oncol. 2017 Feb 1;19(2):252-258. doi: 10.1093/neuonc/now236. Erratum in: Neuro Oncol. 2017 Feb 1;19(2):e1.

7.

Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).

Moots PL, O'Neill A, Londer H, Mehta M, Blumenthal DT, Barger GR, Grunnet ML, Grossman S, Gilbert MR, Schiff D.

Am J Clin Oncol. 2018 Jun;41(6):588-594. doi: 10.1097/COC.0000000000000326.

8.

GBM-associated mutations and altered protein expression are more common in young patients.

Ferguson SD, Xiu J, Weathers SP, Zhou S, Kesari S, Weiss SE, Verhaak RG, Hohl RJ, Barger GR, Reddy SK, Heimberger AB.

Oncotarget. 2016 Oct 25;7(43):69466-69478. doi: 10.18632/oncotarget.11617.

9.

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.

Buckner JC, Shaw EG, Pugh SL, Chakravarti A, Gilbert MR, Barger GR, Coons S, Ricci P, Bullard D, Brown PD, Stelzer K, Brachman D, Suh JH, Schultz CJ, Bahary JP, Fisher BJ, Kim H, Murtha AD, Bell EH, Won M, Mehta MP, Curran WJ Jr.

N Engl J Med. 2016 Apr 7;374(14):1344-55. doi: 10.1056/NEJMoa1500925.

10.

Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI.

Bosnyák E, Kamson DO, Robinette NL, Barger GR, Mittal S, Juhász C.

J Neurooncol. 2016 Jan;126(2):317-25. doi: 10.1007/s11060-015-1970-3. Epub 2015 Oct 29.

11.

Imaging cerebral tryptophan metabolism in brain tumor-associated depression.

Bosnyák E, Kamson DO, Behen ME, Barger GR, Mittal S, Juhász C.

EJNMMI Res. 2015 Dec;5(1):56. doi: 10.1186/s13550-015-0136-9. Epub 2015 Oct 17.

12.

Multi-modal imaging of tumor cellularity and Tryptophan metabolism in human Gliomas.

Jeong JW, Juhász C, Mittal S, Bosnyák E, Kamson DO, Barger GR, Robinette NL, Kupsky WJ, Chugani DC.

Cancer Imaging. 2015 Aug 6;15:10. doi: 10.1186/s40644-015-0045-1.

13.

Clinical significance of tryptophan metabolism in the nontumoral hemisphere in patients with malignant glioma.

Kamson DO, Lee TJ, Varadarajan K, Robinette NL, Muzik O, Chakraborty PK, Snyder M, Barger GR, Mittal S, Juhász C.

J Nucl Med. 2014 Oct;55(10):1605-10. doi: 10.2967/jnumed.114.141002. Epub 2014 Sep 4.

14.

Increased tryptophan uptake on PET has strong independent prognostic value in patients with a previously treated high-grade glioma.

Kamson DO, Mittal S, Robinette NL, Muzik O, Kupsky WJ, Barger GR, Juhász C.

Neuro Oncol. 2014 Oct;16(10):1373-83. doi: 10.1093/neuonc/nou042. Epub 2014 Mar 26.

15.

Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02.

Prabhu RS, Won M, Shaw EG, Hu C, Brachman DG, Buckner JC, Stelzer KJ, Barger GR, Brown PD, Gilbert MR, Mehta MP.

J Clin Oncol. 2014 Feb 20;32(6):535-41. doi: 10.1200/JCO.2013.53.1830. Epub 2014 Jan 13.

16.
17.

Central diabetes insipidus and adipsia due to astrocytoma: diagnosis and management.

Modawi I, Barger GR, Rossi NF.

CEN Case Rep. 2013 May;2(1):11-16. doi: 10.1007/s13730-012-0030-5. Epub 2012 Aug 9.

18.

Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies.

Zitron IM, Thakur A, Norkina O, Barger GR, Lum LG, Mittal S.

BMC Cancer. 2013 Feb 22;13:83. doi: 10.1186/1471-2407-13-83.

19.

Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates.

Kamson DO, Juhász C, Buth A, Kupsky WJ, Barger GR, Chakraborty PK, Muzik O, Mittal S.

J Neurooncol. 2013 Mar;112(1):121-32. doi: 10.1007/s11060-013-1043-4. Epub 2013 Jan 9.

20.

Quantitative PET imaging of tryptophan accumulation in gliomas and remote cortex: correlation with tumor proliferative activity.

Juhász C, Chugani DC, Barger GR, Kupsky WJ, Chakraborty PK, Muzik O, Mittal S.

Clin Nucl Med. 2012 Sep;37(9):838-42. doi: 10.1097/RLU.0b013e318251e458.

21.

Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802.

Shaw EG, Wang M, Coons SW, Brachman DG, Buckner JC, Stelzer KJ, Barger GR, Brown PD, Gilbert MR, Mehta MP.

J Clin Oncol. 2012 Sep 1;30(25):3065-70. doi: 10.1200/JCO.2011.35.8598. Epub 2012 Jul 30.

22.

Accurate differentiation of recurrent gliomas from radiation injury by kinetic analysis of α-11C-methyl-L-tryptophan PET.

Alkonyi B, Barger GR, Mittal S, Muzik O, Chugani DC, Bahl G, Robinette NL, Kupsky WJ, Chakraborty PK, Juhász C.

J Nucl Med. 2012 Jul;53(7):1058-64. doi: 10.2967/jnumed.111.097881. Epub 2012 May 31.

23.

Differential kinetics of α-[¹¹C]methyl-L-tryptophan on PET in low-grade brain tumors.

Juhász C, Muzik O, Chugani DC, Chugani HT, Sood S, Chakraborty PK, Barger GR, Mittal S.

J Neurooncol. 2011 May;102(3):409-15. doi: 10.1007/s11060-010-0327-1. Epub 2010 Jul 30.

24.

Imaging correlates of differential expression of indoleamine 2,3-dioxygenase in human brain tumors.

Batista CE, Juhász C, Muzik O, Kupsky WJ, Barger G, Chugani HT, Mittal S, Sood S, Chakraborty PK, Chugani DC.

Mol Imaging Biol. 2009 Nov-Dec;11(6):460-6. doi: 10.1007/s11307-009-0225-0. Epub 2009 May 12.

25.

Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial.

Shaw EG, Berkey B, Coons SW, Bullard D, Brachman D, Buckner JC, Stelzer KJ, Barger GR, Brown PD, Gilbert MR, Mehta M.

J Neurosurg. 2008 Nov;109(5):835-41. doi: 10.3171/JNS/2008/109/11/0835.

26.

Low-grade gliomas in adults.

Mittal S, Szlaczky MC, Barger GR.

Curr Treat Options Neurol. 2008 Jul;10(4):271-84.

PMID:
18579014
27.

Gliosarcoma with multiple extracranial metastases: case report and review of the literature.

Beaumont TL, Kupsky WJ, Barger GR, Sloan AE.

J Neurooncol. 2007 May;83(1):39-46. Epub 2006 Dec 14. Review.

PMID:
17171442
28.

Cell-based assays using primary endothelial cells to study multiple steps in inflammation.

Mayer T, Jagla B, Wyler MR, Kelly PD, Aulner N, Beard M, Barger G, Többen U, Smith DH, Brandén L, Rothman JE.

Methods Enzymol. 2006;414:266-83.

PMID:
17110197
29.

In vitro drug response and molecular markers associated with drug resistance in malignant gliomas.

Fruehauf JP, Brem H, Brem S, Sloan A, Barger G, Huang W, Parker R.

Clin Cancer Res. 2006 Aug 1;12(15):4523-32.

31.

Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses.

Sehgal V, Delproposto Z, Haddar D, Haacke EM, Sloan AE, Zamorano LJ, Barger G, Hu J, Xu Y, Prabhakaran KP, Elangovan IR, Neelavalli J, Reichenbach JR.

J Magn Reson Imaging. 2006 Jul;24(1):41-51.

PMID:
16755540
32.

In vivo uptake and metabolism of alpha-[11C]methyl-L-tryptophan in human brain tumors.

Juhász C, Chugani DC, Muzik O, Wu D, Sloan AE, Barger G, Watson C, Shah AK, Sood S, Ergun EL, Mangner TJ, Chakraborty PK, Kupsky WJ, Chugani HT.

J Cereb Blood Flow Metab. 2006 Mar;26(3):345-57.

PMID:
16079785
33.

History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.

Wrensch M, Weinberg A, Wiencke J, Miike R, Sison J, Wiemels J, Barger G, DeLorenze G, Aldape K, Kelsey K.

Am J Epidemiol. 2005 May 15;161(10):929-38.

PMID:
15870157
34.

Reduced immunoglobulin E and allergy among adults with glioma compared with controls.

Wiemels JL, Wiencke JK, Patoka J, Moghadassi M, Chew T, McMillan A, Miike R, Barger G, Wrensch M.

Cancer Res. 2004 Nov 15;64(22):8468-73.

35.

Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors.

Chang SM, Seiferheld W, Curran W, Share R, Atkins J, Choucair A, Kresl J, Thoron L, Cairncross G, Gilbert M, Bahary JP, Dolinskas C, Louis DN, Bushunow P, Buckner J, Barger G, Mehta M.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1122-6.

PMID:
15234047
36.

Radiation Therapy Oncology Group. Research Plan 2002-2006. Brain Tumor Committee.

Mehta M, Yung WK, Bullard D, Barger G, Choucair A, Gillin M, Grossman S, Guha A, Hammond ME, Michalski J, Prados M, Provins S, Scott C, Zamorano L; Radiation Therapy Oncology Group.

Int J Radiat Oncol Biol Phys. 2001;51(3 Suppl 2):11-8. No abstract available.

PMID:
11641010
37.

Prevalence of antibodies to four herpesviruses among adults with glioma and controls.

Wrensch M, Weinberg A, Wiencke J, Miike R, Barger G, Kelsey K.

Am J Epidemiol. 2001 Jul 15;154(2):161-5.

PMID:
11447050
38.

Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study.

Aldape K, Simmons ML, Davis RL, Miike R, Wiencke J, Barger G, Lee M, Chen P, Wrensch M.

Cancer. 2000 May 15;88(10):2342-9.

PMID:
10820357
39.

Does prior infection with varicella-zoster virus influence risk of adult glioma?

Wrensch M, Weinberg A, Wiencke J, Masters H, Miike R, Barger G, Lee M.

Am J Epidemiol. 1997 Apr 1;145(7):594-7.

PMID:
9098175
40.

Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls.

Wrensch M, Lee M, Miike R, Newman B, Barger G, Davis R, Wiencke J, Neuhaus J.

Am J Epidemiol. 1997 Apr 1;145(7):581-93.

PMID:
9098174
41.
42.

Familial factors associated with malignant gliomas.

Wrensch MR, Barger GR.

Genet Epidemiol. 1990;7(4):291-301.

PMID:
2227374
43.

Improving patient care through problem-solving groups.

Barger G, Hofmann P, Shumake J, Davies W.

Health Prog. 1987 Sep;68(7):42-5.

PMID:
10283481
44.

Arthritis care in older-adult centers. A controlled study of an education program for public health nurses.

Mazzuca SA, Barger GJ, Brandt KD.

Arthritis Rheum. 1987 Mar;30(3):275-80.

PMID:
3566820
45.

The institutional chaplain: constructing a role definition.

Barger GW, Austil B, Holbrook J, Newton J.

J Pastoral Care. 1984 Sep;38(3):176-86.

PMID:
10267966
46.

Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastoma.

Levin VA, Vestnys PS, Edwards MS, Wara WM, Fulton D, Barger G, Seager M, Wilson CB.

Cancer. 1983 Apr 15;51(8):1364-70.

PMID:
6687443
47.

Stem cell studies of human malignant brain tumors. Part 1: Development of the stem cell assay and its potential.

Rosenblum ML, Gerosa MA, Wilson CB, Barger GR, Pertuiset BF, de Tribolet N, Dougherty DV.

J Neurosurg. 1983 Feb;58(2):170-6.

PMID:
6848672
48.

Developing a structure for chaplaincy evaluation.

Barger GW.

Bull Am Protestant Hosp Assoc. 1983;47(3):41-5. No abstract available.

PMID:
10269993
49.

Age-related chemosensitivity of stem cells from human malignant brain tumours.

Rosenblum ML, Gerosa M, Dougherty DV, Reese C, Barger GR, Davis RL, Levin VA, Wilson CB.

Lancet. 1982 Apr 17;1(8277):885-7.

PMID:
6122104
50.

The association of periodic alternating nystagmus with periodic alternating gaze. A case report.

Kennard C, Barger G, Hoyt WF.

J Clin Neuroophthalmol. 1981 Sep;1(3):191-3.

PMID:
6213660

Supplemental Content

Loading ...
Support Center